Dr. Sumin Kang’s Lab at Winship Cancer Institute
November 3, 2016
Written By: Jaewon Jeong
Dr. Sumin Kang’s lab located at Winship Cancer Institute primarily focuses on protein kinase signaling and metabolic process of cancer cells. Cancer cells are able to reprogram metabolic process in order to obtain energy to survive in extreme conditions. The most common reprogramming process is known as the “Warburg Effect.” The cancer cells are able to obtain adenosine triphosphate (ATP) via aerobic glycolysis rather than oxidative phosphorylation. Also, Dr. Kang’s lab uses mouse models in order to study protein kinase inhibitors. In vivo studies are used to study the effect of inhibitors on human cancer cells.
Dr. Kang’s current projects are related to cancer metastasis. Metastasis, a process which cancer cell leaves the tumor and moves to neighboring tissue, is known to cause more than 90% of death from cancer. Breast cancer and squamous cell carcinoma of the head and neck (SCCHN) are common types of cancers, which frequently metastasize to distinct organs. Metastasis can be halted by a process called anoikis, induced cell death when the cell detaches from the extracellular matrix. Metastatic cancer cells have to be resistant to anoikis and survive during the circulation and dissemination. This gives the cancer cells the ability to metastasize. Metastasis to certain sites such as lung or bone may lead the cancer to be incurable. Therefore, identifying the possible therapeutic target is crucial to understand and possibly stop metastasis from occurring.
Oxytocin: The Hormone of Hope, Hype, and Healing
November 7, 2016
Written By: Shweta Sahu
This piece is based off a talk by Larry Young at the Neuroethics in the News discussion, on March 16, where he gave a talk entitled, “Could a ‘love hormone’ rebond our troubled world?”
Due to his work interrogating the role of certain chemicals in vole behavior at Yerkes National Primate Research Center, Dr. Larry Young has come across the problem of his results being portrayed hyperbolically, as the science sometimes goes to fictional lengths. Yet this work has important implications for mental health. To demonstrate this exaggeration as well as its potential, I am going to address: 1. the buildup of the oxytocin hype, 2. the translation of the research and 3. the ethical implications in humans.
Oxytocin and pair bonding
Dr. Young researches oxytocin (OT), a neuropeptide known to be involved in birthing and associated with maternal bonding, and his lab utilizes voles as an experimental model. Their research was founded upon on the idea that prairie voles are highly social, bi-parental, and monogamous by nature while meadow voles are less social, uniparental, and promiscuous. They investigated differences in oxytocin receptor distribution in the brains of prairie voles and meadow voles and found that in the monogamous prairie voles, there are more oxytocin receptors in the reward system of the brain. Young and colleagues then injected oxytocin antagonists into the nucleus accumbens (NAcc), an area implicated in bonding and reward. They found that prairie voles, whose oxytocin receptors were blocked, would not bond when they mated.
In 2004, Dr. Young began studying the neuropeptide vasopressin. The vasopressin receptor gene (Avpr1a) is expressed in another reward area, the ventral pallidum, which was previously associated with pair bonding in monogamous prairie voles. He then expressed this gene into the ventral pallidum of the promiscuous meadow voles. With the “new” vasopressin receptors, the meadows voles subsequently bonded monogamously like the prairie voles. This experiment showed that a fundamental aspect of behavior can be transformed simply by altering a single gene in an animal.
By this time, Young’s research with voles was published in high-impact journals such as Nature. As a result, some media articles made exaggerated claims suggesting that the research was applicable to humans, though Young and his team never said that. The media came up with several catchy titles such as “Monogamouse,” and “Genetics could keep Mickey and Mini together,” and “Love is a drug for prairie voles to score!” It also brought about the question of “the fidelity gene.”
From voles to humans?
The results of the vasopressin and oxytocin research, along with their potential applications in products and the insights gained into the workings of the human body have inspired numerous press releases and even several further scientific studies. In an interesting turn of events, the media coverage inspired Nature to ask Dr. Young to write an essay about love. This signified a transition for Dr. Young wherein he shifted to thinking about the translatability of his work to humans: could a human mother’s love be all that different from a chimp or macaque mother’s love, which in turn is not all that different from a vole mother’s love? Thus, his work at Yerkes shifted to a focus on humans, and his lab sought to discover whether early life experiences can affect our ability to form bonds later in life. Additional research in this area included modeling of depression-like symptoms in voles after the loss of their pair bonded partner and studies of consolation in these animals.
Maternal affection, image courtesy of Wikipedia
The research of Young and his team contributed to a growing body of data suggesting that oxytocin is the pair bonding hormone, not to be confused with the love or “cuddle hormone.” In all the OT hype, Dr. Young and others realized that oxytocin had important applications beyond inducing labor and pair bonding in humans and other mammals. Oxytocin is critical in its role with social affiliation more broadly. In fact, one study found that oxytocin increases gaze and the ability to maintain eye contact. Another study showed that oxytocin enhances the brain reward system responses in men when viewing the faces of their female partner; when husbands were put in scanners and viewed pictures of their wives, the same brain regions are activated in humans and in pair bonding voles.
Oxytocin nasal spray?
One particularly interesting study discovered that the administration of intranasal oxytocin spray in humans can increase trust. This, in turn, led to the production of oxytocin-filled perfumes for people to apply externally, and these “Sniff of Trust” products are available on the market. Examples include: Attrakt, Attrakt for Her, and Connekt, though there is no scientific evidence that has supported their efficacy or even the theory that high enough doses from people’s clothes are able to pass the blood brain barrier and have any kind of significant effect (the best method to reach the desired effects of oxytocin remains to spray it intranasally). Advertising descriptions include calls to “Wear Connekt and be your true, uninhibited self” and to “Enhance Personal Relationships, Enhance Workplace Bonds, Improve Confidence, Increase Positive Self-Awareness, Experience More Empathy.” The ratings for Attrakt for Her got 4.1 stars on Amazon Marketplace and some high praise, most notably one by Valerie Evans:
“I have been using this secretly for about a week. I wanted to see if it affected my husband of 18 years at all. I think it did. He has been a lot more attentive and cuddly the last few days. Every time I turn around he wants a hug, or just wants to hold me. No complaints here 😀 There is no fragrance to this that I can smell which I love so you can wear it with your regular perfume.”
Applications for autism?
Perhaps the most hot button topic in oxytocin research is that it has been implicated as a potential therapy in autism spectrum disorder (ASD), which is currently untreatable with pharmacotherapy. Dr. Young notes that researchers are currently working to find a way to get the brain to stimulate an increase in release of oxytocin by means other than the use of chemical sprays. Moreover, some studies have found that increased concentrations of oxytocin in the brain have increased emotion regulation, eye gaze, and ability to interpret nonverbal facial expressions in patients with ASD.
Eye gaze, image courtesy of Wikipedia
According to Young, this, in turn, incites the ethical consideration of whether parents are justified in seeking intranasal OT to treat their autistic children and whether physicians should be allowed to prescribe intranasal OT to their patients if they deem this appropriate. He also asks, should we use oxytocin to promote sociality beyond just those with ASD? Is this a form of cosmetic pharmacology?
Some people have even begun self-administering oxytocin as well as to their children, regardless of whether they have a confirmed diagnosis or not. An Amazon commenter posted:
“We use this on our 6 year old son who maybe on the spectrum. He has terrible meltdowns and has had problems socially. This works as a miracle cure – sometimes. Sometimes he is engaging and interactive, patient, kind, loving, amazing. Others he still has meltdowns.
“This isn’t an approved treatment but works better than language or sensory therapy ever did on the same issues. Plus it helps him sleep. All in all – definitely amazing.” Experts recommend parents to wait until more is known about the long term effects of using oxytocin to treat ASD and other prosocial disorders, but still, “some parents of children with autism have asked doctors to prescribe it… or have purchased lower-dose versions of the drug over the counter.” After one clinical trial, one 15-year-old patient with Aspergers was given intranasal oxytocin and he immediately started giggling. “Since then, his parents started buying low-dose over-the-counter oxytocin spray, which they keep at home and with the high school nurse.” The patient even notes, “When I’m really stressed or sad, pretty quickly I start feeling a lot more calm. It sort of disrupted the thoughts that were making me nervous.”
Applications for Psychotherapy?
Another ethically controversial scenario Dr. Young raised was the possibility of using OT to promote trust in patients such as for psychotherapy. I’d add that we can venture and ask what this means for the future of healthcare. In accordance with the study that found that oxytocin increases trust, we can theoretically make anyone more trusting, and this has potential applications in all fields! If OT makes people (from any vocation or background) trust more, then patients may open up and tell their doctors and psychiatrists the full extent of their symptoms. In situations outside the medical field, it is possible that investors could look to invest their money in people or corporations they can trust; maybe we could have more effective lawyers once they have 100% trust in their clients, and perhaps everyone wins.
As expected, though, there are many ethical issues to take into consideration before we start entertaining the notion that we can chemically induce trust. Many, including patients in this context of healthcare, often have reasons to withhold trust or choose to cultivate trust over time. Would oxytocin truly enhance or deteriorate the patient-doctor therapeutic alliance? We must ask ourselves, could this actually do more good than harm? Would it be worth it in the grand scheme of things to chemically induce trust or are we fine the way we are, since we have evolved to only produce and utilize a certain amount of oxytocin in our bodies? Could oxytocin assist in positive social interactions in general, even in people who don’t specifically have any diagnoses of ASD or another disorder? Might it even be used for cognitive or moral enhancement? Even now, while the science continues to evolve, there is no shortage of oxytocin consumer products. There is a risk that if consumer use continues to outpace the evidence, then the full therapeutic potential of oxytocin may never be realized. In summary, Dr. Young’s research provides many examples of how creative basic science research can have a tremendous impact for human populations and the importance of scientific engagement with the media to optimize translation and communication of the key messages.